Noubar B. Afeyan, Ph.D.
Flagship Pioneering, Llc
Assets Managed
$1.162B
Holdings
5
Last Quarter
2026 - Q1
Filed Date
16d ago
Growth Rate
258.47%(2Q avg: 134.61%)
Sustained Growth
4 quarters
Portfolio positions
This chart displays the top 10 holdings in Flagship Pioneering, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 5 positions.
Assets under management
The assets under management (AUM) of Flagship Pioneering, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 1.162B in assets, with a quarterly growth rate of 258.47% and a 2-quarter average growth rate of 134.61%. The portfolio is managed by Noubar B. Afeyan, Ph.D., and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
GENB Generate Biomedicines Inc
| 67.45% | $783.414M 62.673M shares@ $12.51 avg price | New Position |
MRNA Moderna Inc
| 20.26% | $235.313M 4.632M shares@ $50.8 avg price | |
SANA Sana Biotechnology Inc
| 6.2% | $72.005M 25.002M shares@ $2.89 avg price | |
FHTX Foghorn Therapeutics Inc
| 5.22% | $60.582M 12.674M shares@ $4.79 avg price | |
MCRB Seres Therapeutics Inc
| 0.89% | $10.252M 1.156M shares@ $8.88 avg price |
1-5 of 5